| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |